First Eagle Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-1,056,150
Closed -$57.5M 332
2015
Q3
$57.5M Buy
1,056,150
+377,850
+56% +$24.6M 0.14% 118
2015
Q2
$45.6M Buy
+678,300
New +$44.3M 0.11% 126
2015
Q1
Sell
-1,016,097
Closed -$66.5M 333
2014
Q4
$66.5M Buy
+1,016,097
New +$64.1M 0.16% 110

Other funds holding ABBV

First Eagle Investment Management's ABBV Position: Q4 2015 in Review

First Eagle Investment Management sold out of AbbVie (ABBV) in Q4 2015, closing a stake of 1,056,150 shares — an estimated $57.5M sold.

First Eagle Investment Management first reported a position in ABBV in Q4 2014 and held it in 3 quarters. The position peaked at $66.5M in Q4 2014. 1,637 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

  • First Eagle Investment Management reported no remaining AbbVie position as of Q4 2015 after selling out during the quarter.
  • First Eagle Investment Management sold 1,056,150 AbbVie shares in Q4 2015, an estimated $57.5M.
  • First Eagle Investment Management first reported a position in AbbVie in Q4 2014 and held it in 3 quarters.
  • First Eagle Investment Management's AbbVie position peaked at $66.5M in Q4 2014.
  • 1,637 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on First Eagle Investment Management's 13F filing for Q4 2015, filed 12 Feb 2016.